Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early REperfusion Therapy with Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion (REVISION): Study Protocol of a Phase III Trial.
Poli S, Grohmann C, Wenzel DA, Poli K, Tuennerhoff J, Nedelmann M, Fiehler J, Agostini H, Campbell B, Fischer DM, Sykora M, Mac Grory B, Feltgen N, Seiffge DJ, Strbian D, Schultheiß M, Spitzer MS. Poli S, et al. Among authors: agostini h. Int J Stroke. 2024 Apr 9:17474930241248516. doi: 10.1177/17474930241248516. Online ahead of print. Int J Stroke. 2024. PMID: 38591748
LASER FLARE PHOTOMETRY IN PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT: An Evaluation of 2,487 Cases.
Gietzelt C, Hoerster R, Schiller P, Hermann S, Kraus D, Holz FG, Guthoff R, Agostini H, Spitzer MS, Wiedemann P, Lommatzsch A, Boden KT, Bartz-Schmidt U, Bemme S, Tamm S, Maier M, Roider J, Kirchhof B, Fauser S, Schaub F; PRIVENT Study Group. Gietzelt C, et al. Among authors: agostini h. Retina. 2024 May 1;44(5):764-773. doi: 10.1097/IAE.0000000000004026. Retina. 2024. PMID: 38181515 Clinical Trial.
Vitrectomy with or without encircling band for pseudophakic retinal detachment: a multi-centre, three-arm, randomised clinical trial. VIPER Study Report No. 1--design and enrolment.
Mazinani B, Baumgarten S, Schiller P, Agostini H, Helbig H, Limburg E, Hellmich M, Walter P; VIPER Study Group. Mazinani B, et al. Among authors: agostini h. Br J Ophthalmol. 2016 Mar;100(3):405-10. doi: 10.1136/bjophthalmol-2015-306732. Epub 2015 Jul 21. Br J Ophthalmol. 2016. PMID: 26198280 Free PMC article. Clinical Trial.
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Ophthalmology. 2024 Feb 19:S0161-6420(24)00134-9. doi: 10.1016/j.ophtha.2024.02.014. Online ahead of print. Ophthalmology. 2024. PMID: 38382813 Free article.
287 results